114 related articles for article (PubMed ID: 877053)
1. [Drugs needed for treatment of patients with hemoblastosis].
Lebedev VN; Sarkisian SP
Probl Gematol Pereliv Krovi; 1977 Jun; 22(6):45-8. PubMed ID: 877053
[No Abstract] [Full Text] [Related]
2. [The therapy of hemoblastosis and malignant lymphoma. I. Leukosis, polycythemia vera and osteomyelosclerosis].
Löffler H; Schultis K
Med Welt; 1968 Jan; 1():96-100. PubMed ID: 5704123
[No Abstract] [Full Text] [Related]
3. [Cytostatic therapy of hemoblastosis].
Ehrhart H
Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
[No Abstract] [Full Text] [Related]
4. [Stidoes pf the production of precipitating antibodies in conditions of therapeutic immunosuppression].
Luca N
Med Interna (Bucur); 1972 May; 24(5):577-82. PubMed ID: 4626131
[No Abstract] [Full Text] [Related]
5. [Drug therapy in hemoblastosis].
Bischof B
Folia Clin Int (Barc); 1968 Jun; 18(6):365-8. PubMed ID: 4988909
[No Abstract] [Full Text] [Related]
6. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
7. The effect of Milurit on secondary hyperuricaemia following cytostatic treatment in haemoblastosis patients.
Bodrogi I; Bálint I
Ther Hung; 1979; 27(2):77-83. PubMed ID: 494144
[No Abstract] [Full Text] [Related]
8. Polycythemia vera: diagnosis and treatment 2002.
Berlin NI
Expert Rev Anticancer Ther; 2002 Jun; 2(3):330-6. PubMed ID: 12113056
[TBL] [Abstract][Full Text] [Related]
9. Pipobroman (Vercyte) - a new antineoplastic drug.
Med Lett Drugs Ther; 1967 Apr; 9(7):27. PubMed ID: 5298493
[No Abstract] [Full Text] [Related]
10. [The treatment of chronic hemoblastosis with new cytostatic agents].
Quattrin N
Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
[No Abstract] [Full Text] [Related]
11. [Evaluation of chemotherapy of hematological malignancies].
Masaoka T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):316-22. PubMed ID: 2649005
[TBL] [Abstract][Full Text] [Related]
12. [Secondary carcinoma: a complication of cytostatic therapy?].
Queisser W; Kalb M
Med Klin; 1979 Oct; 74(40):1422-30. PubMed ID: 492063
[No Abstract] [Full Text] [Related]
13. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
[TBL] [Abstract][Full Text] [Related]
14. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
[No Abstract] [Full Text] [Related]
15. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
16. Leukemia and the hypercoagulable state. Pathogenic and therapeutic implications.
Brodsky I
J Med; 1974; 5(1):38-49. PubMed ID: 4524857
[No Abstract] [Full Text] [Related]
17. [Cytostatic treatment of polycythemia vera with a methylbenzylhydrazine derivative].
Martin H; Schubert JC
Dtsch Med Wochenschr; 1966 Jan; 91(2):55-7. PubMed ID: 5900941
[No Abstract] [Full Text] [Related]
18. [Treatment of polycythemia vera].
Pribilla W
Dtsch Med J; 1968 Jun; 19(12):441-3. PubMed ID: 4891144
[No Abstract] [Full Text] [Related]
19. Management of polycythemia vera with hydroxyurea.
Tatarsky I; Sharon R
Semin Hematol; 1997 Jan; 34(1):24-8. PubMed ID: 9025159
[No Abstract] [Full Text] [Related]
20. [Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
Bilski-Pasquier G; Blanc CM; Bousser J
Presse Med (1893); 1968 Oct; 76(41):1953-6. PubMed ID: 5248051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
